-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Connect with us
Get in touch with us

Chat with us
Click the icon in the bottom right corner to chat with us
(8 am to 8 pm EST)

Medical information contact center
Ask scientific questions about our medical products, report adverse events or submit product quality complaints.

Call us
Call us to speak to an operator
US toll free 1-844-NOVAVAX (668-2829) (8 am to 8 pm EST)

Email us
For all general inquiries, please email us and we will be happy to respond within a few days.
PLEASE NOTE:
If you are participating in a Novavax COVID-19 vaccine clinical trial and have experienced an adverse event please notify your coordinating study site.